Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!

Allison B. Hall; Emmanouil S. Brilakis

doi:10.1002/ccd.28011

Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!

Allison B. Hall, Emmanouil S. Brilakis

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Abstract

Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein graft Angioplasty and Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? Trial) definitely show no difference between the two stent types, suggesting that bare metal stents should be preferred given lower cost. Since SVG stenting remains associated with high failure rates, alternative treatment strategies, such as intervention of the corresponding native coronary artery lesions, may represent the future direction of the field.

Original language	English (US)
Pages (from-to)	E193-E194
Journal	Catheterization and Cardiovascular Interventions
Volume	93
Issue number	3
DOIs	https://doi.org/10.1002/ccd.28011
State	Published - Feb 15 2019
Externally published	Yes

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1002/ccd.28011

Cite this

@article{047b733925a94b32bb6558ff76db5231,

title = "Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!",

abstract = "Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein graft Angioplasty and Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? Trial) definitely show no difference between the two stent types, suggesting that bare metal stents should be preferred given lower cost. Since SVG stenting remains associated with high failure rates, alternative treatment strategies, such as intervention of the corresponding native coronary artery lesions, may represent the future direction of the field.",

author = "Hall, {Allison B.} and Brilakis, {Emmanouil S.}",

note = "Publisher Copyright: {\textcopyright} 2019 Wiley Periodicals, Inc.",

year = "2019",

month = feb,

day = "15",

doi = "10.1002/ccd.28011",

language = "English (US)",

volume = "93",

pages = "E193--E194",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "Wiley-Liss Inc.",

number = "3",

}

TY - JOUR

T1 - Treating saphenous vein graft lesions

T2 - Drug-eluting stents are not the answer!

AU - Hall, Allison B.

AU - Brilakis, Emmanouil S.

PY - 2019/2/15

Y1 - 2019/2/15

N2 - Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein graft Angioplasty and Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? Trial) definitely show no difference between the two stent types, suggesting that bare metal stents should be preferred given lower cost. Since SVG stenting remains associated with high failure rates, alternative treatment strategies, such as intervention of the corresponding native coronary artery lesions, may represent the future direction of the field.

AB - Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein graft Angioplasty and Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? Trial) definitely show no difference between the two stent types, suggesting that bare metal stents should be preferred given lower cost. Since SVG stenting remains associated with high failure rates, alternative treatment strategies, such as intervention of the corresponding native coronary artery lesions, may represent the future direction of the field.

UR - http://www.scopus.com/inward/record.url?scp=85061590885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061590885&partnerID=8YFLogxK

U2 - 10.1002/ccd.28011

DO - 10.1002/ccd.28011

M3 - Editorial

C2 - 30770658

AN - SCOPUS:85061590885

SN - 1522-1946

VL - 93

SP - E193-E194

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

IS - 3

ER -

Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this